Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: out_of_the_loop who wrote (2030)	1/16/2000 12:13:00 AM
From: Mad2	Read Replies (2) \| Respond to of 5582

Geez, I didn't post the article quoting Dr. Romero, John White did. Are you sure about this Howard? Dr. Romero must really be the Joker if he thinks it is a cure for the common cold. Well I guess your the expert, too bad Mr. Haney who wrote the article didn't consult you.....I suppose this guy isn't credible either "There have been a number of anti-picornavirus agents over the past 25 years, but they've had all sorts of problems," said Dr. Mark Pallansch, an enterovirus expert at the U.S. Centers for Disease Control and Prevention. "Pleconaril is the first true, viable product that is potentially licensable." Or "Pleconaril represents a class of drugs that were designed with the knowledge of the three-dimensional structure of the virus," says Dr. Catherine Laughlin, chief of virology at the National Institute of Allergy and Infectious Diseases. "It provides a lot of hope for the eventual design of drugs for virtually every viral infection." Not to mention WLA Certainly other drug makers have. However, only one other company appears to be close to ViroPharma for now. Agouron Pharmaceuticals, a part of Warner-Lambert, is experimenting on 900 cold victims to see if its nasal spray, code-named AG7088, will speed their recovery. Howard you response is typical....shoot the messenger based upon you distorted view.....Yawn Mad2